ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 618857 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 618857; 2) Community: the network communities that were significantly associated with the response to NSC 618857; 3) Molecule: the relationships between components within communities and NSC 618857; 4) MDR: the compounds that were significantly associated with the NSC 618857.

NSC Compound Enrichment Correlation
NSC 736591 Null 0.0177048892222174 -0.011348549
NSC 737606 Null 0.0177048892222174 -0.20665632
NSC 114346 Null 0.0193573267900279 -0.025027943
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0193573267900279 0.15495046
NSC 144126 Null 0.0193573267900279 0.2802272
NSC 303861 L-Cysteine analog 0.0193573267900279 -0.042364721
NSC 30915 Null 0.0193573267900279 -0.12857551
NSC 328410 Camptothecin Derivative 0.0193573267900279 0.31521307
NSC 606499 Camptothecin Derivative 0.0193573267900279 0.12483709
NSC 633963 N,N'-Di{1-methyl-2-[1-methyl-2-carboxamido(3-propionamidine) -4-pyrrole]-4-pyrrolyl}suberamide dihydrochloride 0.0193573267900282 -0.13741943
Total:60  Current:24    [First] [Prev] [Next] [Last]